rho GTPase Activating Protein 36 (ARHGAP36) (N-Term) Peptide
Quick Overview for rho GTPase Activating Protein 36 (ARHGAP36) (N-Term) Peptide (ABIN1542409)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Sequence
- KPDRALPIDR PNTLDKWFLI LRGQQRAVSH KTFGISLEEV LVNEFTRRKH
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-RP13-102H20.1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- ARHGAP36 (rho GTPase Activating Protein 36 (ARHGAP36))
-
Background
-
RP13-102H20.1 is the GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state.
Alias Symbols: FLJ30058
Protein Size: 547 -
Molecular Weight
- 62 kDa
-
Gene ID
- 158763
-
NCBI Accession
- NM_144967, NP_659404
-
UniProt
- Q6ZRI8
Target
-